YOURSCIENCEBE: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
YOURSCIENCEBE
Largest movements
- Cash -€12,905
down €12,905 (-29.8%), from €43,292 to €30,387
mainly Tax, wage and social debts (-€6,540) and Net result for the year (-€5,102)
- Receivables within one year +€1,272
up €1,272 (+24.2%), from €5,266 to €6,538
- Tax, wage and social debts -€6,540
down €6,540 (-76.3%), from €8,567 to €2,027
- Profit (loss) carried forward -€5,102
down €5,102 (-14.9%), from €34,267 to €29,165
- Gross operating margin -€15,177
down €15,177, from €10,543 to -€4,634
- Taxes -€2,027
no longer reported in 2025 (was €2,027)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €48,558 | €36,944 | -€11,613 | -23.9% |
| Current assets | 29/58 | €48,558 | €36,944 | -€11,613 | -23.9% |
| Amounts receivable within one year | 40/41 | €5,266 | €6,538 | +€1,272 | +24.2% |
| Other amounts receivable | 41 | €5,266 | €6,538 | +€1,272 | +24.2% |
| Cash at bank and in hand | 54/58 | €43,292 | €30,387 | -€12,905 | -29.8% |
| Deferred charges and accrued income | 490/1 | - | €19 | +€19 | |
| Total equity and liabilities | 10/49 | €48,558 | €36,944 | -€11,613 | -23.9% |
| Equity | 10/15 | €36,267 | €31,165 | -€5,102 | -14.1% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €34,267 | €29,165 | -€5,102 | -14.9% |
| Amounts payable | 17/49 | €12,291 | €5,779 | -€6,511 | -53.0% |
| Amounts payable within one year | 42/48 | €12,291 | €5,779 | -€6,511 | -53.0% |
| Taxes, remuneration and social security | 45 | €8,567 | €2,027 | -€6,540 | -76.3% |
| Taxes | 450/3 | €8,567 | €2,027 | -€6,540 | -76.3% |
| Other amounts payable | 47/48 | €3,724 | €3,753 | +€29 | +0.8% |
| Gross operating margin | 9900 | €10,543 | -€4,634 | -€15,177 | |
| Operating profit (loss) | 9901 | €10,543 | -€4,634 | -€15,177 | |
| Financial income | 75/76B | €38 | €36 | -€2 | -5.3% |
| Recurring financial income | 75 | €38 | €36 | -€2 | -5.3% |
| Financial charges | 65/66B | €447 | €504 | +€57 | +12.8% |
| Recurring financial charges | 65 | €447 | €504 | +€57 | +12.8% |
| Profit (loss) for the period before taxes | 9903 | €10,134 | -€5,102 | -€15,236 | |
| Income taxes | 67/77 | €2,027 | - | -€2,027 | |
| Profit (loss) for the period | 9904 | €8,107 | -€5,102 | -€13,209 | |
| Profit (loss) for the period to be appropriated | 9905 | €8,107 | -€5,102 | -€13,209 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.